Introduction
The prevalence of obesity increases rapidly in most countries. Although the environmental contribution to the obesity epidemic is apparent, there is a strong genetic component of obesity as well. As much as 50 ± 70% of variations in body mass index can be attributed to genetic difference. In this review, the notion is brought about that several important obesity genes may be involved in the regulation of human adipose tissue function so that they may cause excess body fat by a direct interaction with the fat cell. In the interest of space, review articles rather than original papers will be cited whenever possible.
Rare forms of monogenic obesity
Most of the monogenic obesities in rodent models have recently been identi®ed. Some of these genes may cause rare forms of monogenic obesity in humans. Mutations in the human genes coding for leptin, 1 leptin receptor, 2 proopiomelanocortin, 3 prohormone convertase-1 4 and melanocortin-4 receptor 5 have been described which all associate with juvenile onset morbid obesity. The mechanisms responsible for excess fat accumulation in the rare forms of monogenic human obesity are not known. As regards the leptin mutation it was recently shown that leptin administration normalized the phenotype in an obese child lacking the hormone. 6 Several of the genes causing monogenic obesity have been screened among large populations but no important associations with obesity have been found. 7 The genes involved in common forms of human obesity
The genes of importance for common forms of human obesity remain to be detected. A number of chromosomes have been identi®ed using a genome-wide scan approach in family studies; at least one major obesity gene may be located on chromosomes number 2, 8 number 10, 9 number 11 10 and number 20. 11 The locus in each of these chromosomes is not identi®ed so we do not know which genes and which mutation(s) in the genes is (are) associated with obesity.
It is thought that obesity is the result of an interaction between several genes and environmental factors in a certain individual. Using the candidate gene approach, a number of polymorphisms in different genes have recently been found to be linked to human obesity. It is apparent that all of these are in control of major functions of adipose tissue. In the rest of this paper I will discuss the relative importance of adipose genes for human obesity.
The b 2 -adrenoceptor is involved in the regulation of energy homeostasis in many ways, for example by stimulation of glycogen breakdown and stimulation of lipid mobilization. The b-receptor in human fat cells co-exists with b 1 -and b 3 -adrenoceptors in human white adipose tissue. Under normal conditions the b 2 -adrenoceptor is the dominant lipolytic adrenoceptor subtype, but it is downregulated in subcutaneous adipose tissue of obese subjects. A b 2 -receptor dysfunction could be an important underlying mechanism behind the established lipolytic catecholamine resistance in human obesity.
Several coding and functional mutations in the b 2 -adrenocpetor gene are described. These polymorphisms associate with altered receptor function in human white fat cells. 12 One polymorphism, Gln27Glu, has a strong association with obesity in some 12 but not all 13 studies. The Gln27Glu polymorphism may be subjected to gene ± environmental interactions. 14 An interaction with physical activity is demonstrated; it associates with obesity in sedentary but not in physically active subjects.
The Gln27Glu polymorphism may in combination with physical inactivity in¯uence body fat accumulation by altering the lipolytic response of adipose tissue lipolytic response to catecholamines. Since the b 2 -adrenoceptors have a number of unrelated effects on energy homeostasis there are, of course, several other possibilities by which this receptor may promote obesity.
The association between obesity and a coding mutation in the b 3 -adrenergic receptor (Trp64Arg) has been frequently investigated. 15 About half of the obesity studies show an association with overweight, whereas the other half fail to demonstrate a link to excess body fat. Even meta-analyses show divergent results as regards the importance of the Trp64Arg polymorphism for obesity. 16, 17 Despite the discrepant ®ndings it is quite possible that the b 3 -adrenoceptor is an important obesity gene.
The b 3 -adrenoceptor is expressed and functional in white and brown fat cells. 36, 37 The brown adipose tissue mass is small in adult humans, but the thermogenic effect can be activated by b 3 -adrenergic agonists in brown human fat cells. b 3 -receptors can also stimulate lipolysis in white human adipose tissue. The receptor is, though, less ef®cient in the latter respect than the co-existing b 1 -and b 2 -subtypes. The Trp64Arg substitution in the b 3 -adrenoceptor molecule impairs the receptor function in human fat cells. 18 When all available information is considered together, it is not unlikely that the adipocyte b 3 -adrenoceptor is an obesity gene. A Trp64Arg mutation impairs receptor function and is associated with decreased thermogenesis and also obesity in some (but not all) populations.
Hormone sensitive lipase
Hormone sensitive lipase is an important lipolysisregulating protein. The enzyme is the ®nal rate-limiting step for triglyceride break-down in fat cells when lipolysis is stimulated by catecholamines or inhibited by insulin. Although the enzyme is also functionally expressed in skeletal muscle and testis, the physiological importance in the latter two tissues is not understood. It is well established that the ability of catecholamines to stimulate lipolysis in subcutaneous adipose tissue is decreased in obesity. This lipolysis defect is at least in part explained by a decreased expression of hormone sensitive lipase in adipocytes and a similar lipolysis defect is found in non-obese subjects with heredity for obesity.
The hormone sensitive lipase gene seems to be linked with obesity. A non-coding dinucleotide repeat and other forms of genetic variability, which are detected by restriction-length fragment polymorphism, associate with obesity in different populations. 19, 20 It remains to be established if structural variants in the hormone sensitive lipase gene also alter protein expression or enzyme function. The detected polymorphisms in hormone sensitive lipase could also re¯ect more important variations on genes near the hormone sensitive lipase locus. However, no such evidence has been found so far. 21 When genetic and functional data are combined it could be tempting to speculate that genetic variance impairs hormonesensitive lipase so that lipolysis in fat cells is decreased in a way which may promote obesity.
Peroxisome proliferator activated receptor gamma-2 (PPARg-2)
The peroxisome pro®lerator activated receptor PPARg-2 is a key regulator of adipocyte differentiation. The mRNA levels for PPARg-2 are increased in adipose tissue of obese subjects. Two functional coding mutations have been described in PPARg-2. The Pro115Gln polymorphism in¯uences the differentiation of adipocytes and is associated with morbid obesity. 22 The Pro12Ala polymorphism is linked to decreased receptor activity and lower body mass index. 23 The PPARg-2 mutations occur in about 10% of the population but homozygous subjects are very rare. Only a handful of homozygous subjects have been described; heterozygotes seem to have a normal phenotype. 24 More research is needed before we know if PPARg-2 is an important obesity gene. It is, however, possible that genetic variance in PPARg-2 changes adipocyte differentiation so that an excess fat mass is developed.
Uncoupling proteins
The uncoupling proteins (UCP) uncouple ATP production from mitochondrial respiration, producing heat so that energy expenditure is enhanced. A family of proteins has been discovered. UCP-1 is only expressed in brown adipose tissue and regulates the combustion of fatty acids in brown fat cells. In human newborns brown adipose tissue is present in considerable amounts and is important for thermogenesis in the early phases of life. Little brown adipose tissue is present in adults but small amounts of brown fat cells are found in several human tissues. Furthermore, gene expression of UCP-1 is decreased in white adipose tissue of obese lean adult subjects. As mentioned UCP-1 can be activated in human adipose tissue by b 3 -adrenergic agonists in vivo or in vitro. The role of the other UCPs is not elucidated yet. UCP-2 is expressed in adipose tissue and several other tissues. UCP-3, on the other hand, is predominantly expressed in skeletal muscle. The tissue mRNA levels for both UCP-2 and UCP-3 are in¯uenced by the obese state in humans.
Polymorphisms in the genes for UCP-2 and -3 show association to resting metabolic rate but it appears that none of the genes has an important role in human obesity. 25, 26 However, a polymorphism (A(À3826)G) in the promotor region of the UCP-1 gene in¯uences body weight gain in different populations of obese subjects. There are also signi®cant interactions between the genes for UCP-1 and the b 3 -adrenergic receptor. Synergistic effects of (A(À3826)G) in UCP-1 and Trp64Arg in b 3 -adrenoceptor on resting metabolic rate 27 and on changes in body weight 28, 29 have been reported. However no relationship between the UCP-1 polymorphism and obesity was found in a Swedish population. 30 When all the ®ndings discussed above are considered together it is possible that UCP-1 is an obesity gene by in¯uencing the metabolic rate. The thermogenic effect may be of particular importance when polymorphisms in UCP-1 and the b 3 -adrenoceptor genes co-exist.
Tumor necrosis factor alpha (TNFa)
TNFa is a cytokine which modulates the expression of several genes in adipose tissue, and TNFa is believed to play a role in the development of obesity. One important obesity effect of TNFa is the ability of the cytokine to modulate insulin sensitivity; this is above all achieved by inhibiting insulin signaling in fat cells. The cytokine can also induce apoptosis of fat cells and stimulate lipolysis; the latter is achieved by decreasing the expression of the lipolysis inhibiting Gi protein in adipocytes. These different effects of TNFa may also regulate the fat mass.
A linkage between TNFa and body fat content has been demonstrated. 31 A polymorphism near the transcription start site of TNFa (G to A at position À308) has been associated with obesity in several populations. 32, 33 It was recently found that the latter polymorphism only in¯uences body fat content in its homozygous form 34 in turn, suggesting that TNFa is a recessive obesity gene. The effect of the À308 polymorphism on TNFa function is unknown but in vitro studies indicate that it in¯uences the transcription of the TNFa gene. 35 TNFa is widely expressed. It has also several divergent actions which could in¯uence storage of body fat in an indirect fashion. On the other hand, it is possible that genetic variance alters the expression of TNFa so that lipolysis, insulin sensitivity and apoptosis in adipose tissue is changed in a way which promotes obesity.
Low-density lipoprotein receptor (LDL-R)
LDL-R is a commonly expressed receptor and has multiple roles in lipid metabolism. In adipose tissue LDL-R mediates the uptake of lipids from remnant lipoproteins by fat cells. A polymorphic marker near the locus for LDL-R has a relatively strong linkage to obesity in many populations. 7 The functional nature of this polymorphism is not known. Several obesity promoting mechanisms not directly involving adipose tissue are possible for LDL-R. It is tempting, though, to speculate that structural variance in the LDL-R gene leads to increased lipid uptake by adipose tissue so that obesity is developed.
Other genes
A number of polymorphisms in other genes than those mentioned above have been investigated regarding an association to obesity. 7 These genes have in general no known important function in adipose tissue. Either no or a weak association between the`non-adipose tissue' genes and obesity has been shown and often only a single report for each gene is published.
Gender and obesity genes
Body distribution usually differs between men and women. Upper-body obesity is most common in men and peripheral obesity is most common in women. It is suggested that body fat distribution is governed by genetic factors. 36 Many of the polymorphisms mentioned in this review seem to play different roles for body fat accumulation in men vs women.
The Trp64Arg polymorphism in the b 3 -adrenoceptor is only associated with obesity among women according to several studies. 15 The Gln27Glu polymorphism in the b 2 -adrenoceptor is linked to obesity in women but not in men in one study. 37 The TNFa AaG(À308) polymorphism gene is associated with female obesity but not male obesity. 34 The LDL-R microsatellite variant was only associated with obesity in females. 38 These data indicate that the obesity genes differ between the sexes. So far a number of`female' obesity genes but no`male' obesity genes have been identi®ed. More studies are needed to sort out the interactions between gender, genes and obesity.
Conclusions
The knowledge about the genetics behind obesity has increased considerably in recent years. Some of these genes may cause excess fat accumulation in a few human subjects in a monogenic way. On the other hand, the genetic control of common forms of human obesity is poorly understood. It appears that several genes (together with environmental factors) are in control of body fat stores. 39, 40 Through the candidate gene approach some of these genes have been identi®ed. The candidate genes associate with obesity in some but not all subjects. It is apparent that most of the candidate genes control important functions in adipose tissue (see Table 1 for an overview). It could therefore be suggested that structural variations in those genes may alter adipose tissue function in a way that promotes the development of obesity. Changes in the genes for b 2 -adrenoceptors, b 3 -adrenoceptors, hormone sensitive lipase and TNFa may inhibit lipolysis. Polymorphism in the TNFa genes could, in addition, improve insulin sensitivity and decrease adipocyte apoptosis. PPARg-2 gene polymorphism might increase adipocyte differentiation. Polymorphism in UCP-1 and b-3 adrenoceptor genes could decrease thermogenesis. Genetic variance in the LDL-R gene may increase lipid storage in adipose tissue. All these variations in the structure of genes controlling adipose tissue function could promote excess body fat accumulation. Some of the genes may interact in the development of obesity such as UCP-1 and b 3 -receptor. Others may promote obesity through gene ± environmental interactions. An example is the interplay between physical activity, the b 2 -adrenoceptor gene and obesity. Finally, obesity genes may differ among women and men. The genes for b 2 -adrenoceptors, b 3 -adrenoceptors, TNFa and LDL-R seem to be of greater importance for obesity among women than in men. It is clear that widely expressed genes such as those encoding for b 2 -adrenoceptor, TNFa and LDL-R could cause overweight in a number of ways besides acting directly on adipose tissue. However, genes for hormone-sensitive lipase, b 3 -adrenoceptor, UCP-1 and PPARg-2 most likely promote obesity by involving directly the fat cells. It is therefore tempting to speculate that polymorphisms in genes controlling the function of adipose tissue are of importance for the development of excess body fat in most humans. Thus, it might be of bene®t to look more into adipose tissue for human obesity genes. Adipose tissue and obesity genes P Arner
